Document Detail


Head lice treatments: Searching for the path of least resistance.
MedLine Citation:
PMID:  19615542     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Based on the dialogue "Head lice" between Drs Kimberly D. Morel and Stephen Stone. Dialogues in Dermatology, a monthly audio program from the American Academy of Dermatology, contains discussions between dermatologists on timely topics. Commentaries from Dialogues Editor-in-Chief Warren R. Heymann, MD, are provided after each discussion as a topic summary and are provided here as a special service to readers of the Journal of the American Academy of Dermatology.
Authors:
Warren R Heymann
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the American Academy of Dermatology     Volume:  61     ISSN:  1097-6787     ISO Abbreviation:  J. Am. Acad. Dermatol.     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-07-20     Completed Date:  2009-08-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7907132     Medline TA:  J Am Acad Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  323-4     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Humans
Incidence
Insecticide Resistance*
Insecticides / therapeutic use*
Lice Infestations / diagnosis,  drug therapy*,  epidemiology
Lindane / therapeutic use
Malathion / therapeutic use
Parasitic Sensitivity Tests
Pediculus / drug effects*
Permethrin / therapeutic use
Risk Assessment
Scalp Dermatoses / diagnosis,  drug therapy*,  epidemiology
Sensitivity and Specificity
Treatment Outcome
Chemical
Reg. No./Substance:
0/Insecticides; 121-75-5/Malathion; 52645-53-1/Permethrin; 58-89-9/Lindane

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology.
Next Document:  Warfarin-induced skin necrosis.